Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P₁) Receptor Agonists with Exceptional Selectivity against S1P₂ and S1P₃

This article is cited by 89 publications.

1. Sun Jun Park, Seul Ki Yeon, Yoowon Kim, Hyeon Jeong Kim, Siwon Kim, Jushin Kim, Ji Won Choi, Byungeun Kim, Elijah Hwejin Lee, Rium Kim, Seon Hee Seo, Jaeick Lee, Jun Woo Kim, Ha-Yeon Lee, Hayoung Hwang, Yong-Sun Bahn, Eunji Cheong, Jong-Hyun Park, Ki Duk Park. Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis. Journal of Medicinal Chemistry 2022, 65 (4) , 3539-3562. https://doi.org/10.1021/acs.jmedchem.1c01979
2. Jin Liu, Heng Li, Kai-Xian Chen, Jian-Ping Zuo, Yue-Wei Guo, Wei Tang, Xu-Wen Li. Design and Synthesis of Marine Phidianidine Derivatives as Potential Immunosuppressive Agents. Journal of Medicinal Chemistry 2018, 61 (24) , 11298-11308. https://doi.org/10.1021/acs.jmedchem.8b01430
3. Alaric J. Dyckman . Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. Journal of Medicinal Chemistry 2017, 60 (13) , 5267-5289. https://doi.org/10.1021/acs.jmedchem.6b01575
4. John L. Gilmore, James E. Sheppeck, II, Scott H. Watterson, Lauren Haque, Parag Mukhopadhyay, Andrew J. Tebben, Michael A. Galella, Ding Ren Shen, Melissa Yarde, Mary Ellen Cvijic, Virna Borowski, Kathleen Gillooly, Tracy Taylor, Kim W. McIntyre, Bethanne Warrack, Paul C. Levesque, Julia P. Li, Georgia Cornelius, Celia D’Arienzo, Anthony Marino, Praveen Balimane, Luisa Salter-Cid, Joel C. Barrish, William J. Pitts, Percy H. Carter, Jenny Xie, and Alaric J. Dyckman . Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1). Journal of Medicinal Chemistry 2016, 59 (13) , 6248-6264. https://doi.org/10.1021/acs.jmedchem.6b00373
5. Adam J. Rosenberg, Hui Liu, Hongjun Jin, Xuyi Yue, Sean Riley, Steven J. Brown, and Zhude Tu . Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer. Journal of Medicinal Chemistry 2016, 59 (13) , 6201-6220. https://doi.org/10.1021/acs.jmedchem.6b00390
6. Scott H. Watterson, Junqing Guo, Steve H. Spergel, Charles M. Langevine, Robert V. Moquin, Ding Ren Shen, Melissa Yarde, Mary Ellen Cvijic, Dana Banas, Richard Liu, Suzanne J. Suchard, Kathleen Gillooly, Tracy Taylor, Sandra Rex-Rabe, David J. Shuster, Kim W. McIntyre, Georgia Cornelius, Celia D’Arienzo, Anthony Marino, Praveen Balimane, Bethanne Warrack, Luisa Salter-Cid, Murray McKinnon, Joel C. Barrish, Percy H. Carter, William J. Pitts, Jenny Xie, and Alaric J. Dyckman . Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series. Journal of Medicinal Chemistry 2016, 59 (6) , 2820-2840. https://doi.org/10.1021/acs.jmedchem.6b00089
7. T. G. Murali Dhar, Hai-Yun Xiao, Jenny Xie, Lois D. Lehman-McKeeman, Dauh-Rurng Wu, Marta Dabros, Xiaoxia Yang, Tracy L. Taylor, Xia D. Zhou, Elizabeth M. Heimrich, Rochelle Thomas, Kim W. McIntyre, Bethanne Warrack, Hong Shi, Paul C. Levesque, Jia L. Zhu, James Hennan, Praveen Balimane, Zheng Yang, Anthony M. Marino, Georgia Cornelius, Celia J. D’Arienzo, Arvind Mathur, Ding Ren Shen, Mary Ellen Cvijic, Luisa Salter-Cid, Joel C. Barrish, Percy H. Carter, and Alaric J. Dyckman . Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials. ACS Medicinal Chemistry Letters 2016, 7 (3) , 283-288. https://doi.org/10.1021/acsmedchemlett.5b00448
8. Emmanuel H. Demont, James M. Bailey, Rino A. Bit, Jack A. Brown, Colin A. Campbell, Nigel Deeks, Simon J. Dowell, Colin Eldred, Pam Gaskin, James R. J. Gray, Andrea Haynes, David J. Hirst, Duncan S. Holmes, Umesh Kumar, Mary A. Morse, Greg J. Osborne, Jessica F. Renaux, Gail A. L. Seal, Chris A. Smethurst, Simon Taylor, Robert Watson, Robert Willis, and Jason Witherington . Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses. Journal of Medicinal Chemistry 2016, 59 (3) , 1003-1020. https://doi.org/10.1021/acs.jmedchem.5b01512
9. John Skidmore, Jag Heer, Christopher N. Johnson, David Norton, Sally Redshaw, Jennifer Sweeting, David Hurst, Andrew Cridland, David Vesey, Ian Wall, Mahmood Ahmed, Dean Rivers, James Myatt, Gerard Giblin, Karen Philpott, Umesh Kumar, Alexander Stevens, Rino A. Bit, Andrea Haynes, Simon Taylor, Robert Watson, Jason Witherington, Emmanuel Demont, and Tom D. Heightman . Optimization of Sphingosine-1-phosphate-1 Receptor Agonists: Effects of Acidic, Basic, and Zwitterionic Chemotypes on Pharmacokinetic and Pharmacodynamic Profiles. Journal of Medicinal Chemistry 2014, 57 (24) , 10424-10442. https://doi.org/10.1021/jm5010336
10. Emmanuel H. Demont, Sandra Arpino, Rino A. Bit, Colin A. Campbell, Nigel Deeks, Sapna Desai, Simon J. Dowell, Pam Gaskin, James R. J. Gray, Lee A. Harrison, Andrea Haynes, Tom D. Heightman, Duncan S. Holmes, Philip G. Humphreys, Umesh Kumar, Mary A. Morse, Greg J. Osborne, Terry Panchal, Karen L. Philpott, Simon Taylor, Robert Watson, Robert Willis, and Jason Witherington . Discovery of a Brain-Penetrant S1P3-Sparing Direct Agonist of the S1P1 and S1P5 Receptors Efficacious at Low Oral Dose. Journal of Medicinal Chemistry 2011, 54 (19) , 6724-6733. https://doi.org/10.1021/jm200609t
11. Ashis K. Saha, Xiang Yu, Jian Lin, Mercedes Lobera, Anurag Sharadendu, Srinivas Chereku, Nili Schutz, Dalia Segal, Yael Marantz, Dilara McCauley, Scot Middleton, Jerry Siu, Roland W. Bürli, Janet Buys, Michelle Horner, Kevin Salyers, Michael Schrag, Hugo M. Vargas, Yang Xu, Michele McElvain, and Han Xu . Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS. ACS Medicinal Chemistry Letters 2011, 2 (2) , 97-101. https://doi.org/10.1021/ml100227q
12. John Kallikat Augustine, Vani Akabote, Shrivatsa Ganapati Hegde and Padma Alagarsamy. PTSA−ZnCl2: An Efficient Catalyst for the Synthesis of 1,2,4-Oxadiazoles from Amidoximes and Organic Nitriles. The Journal of Organic Chemistry 2009, 74 (15) , 5640-5643. https://doi.org/10.1021/jo900818h
13. Grier A. Wallace, Thomas D. Gordon, Martin E. Hayes, Donald B. Konopacki, Shannon R. Fix-Stenzel, Xiaolei Zhang, Pintipa Grongsaard, Kevin P. Cusack, Lisa M. Schaffter, Rodger F. Henry and Robert H. Stoffel . Scalable Synthesis and Isolation of the Four Stereoisomers of Methyl 1-Amino-3-(4-bromophenyl)cyclopentanecarboxylate, Useful Intermediates for the Synthesis of S1P1 Receptor Agonists. The Journal of Organic Chemistry 2009, 74 (13) , 4886-4889. https://doi.org/10.1021/jo900376b
14. Kirill Lukin, Qunying Zhang and M. Robert Leanna. Practical Method for Asymmetric Addition of Arylboronic Acids to α,β-Unsaturated Carbonyl Compounds Utilizing an In Situ Prepared Rhodium Catalyst. The Journal of Organic Chemistry 2009, 74 (2) , 929-931. https://doi.org/10.1021/jo802136j
15. Daniel Grant, Russell Dahl and Nicholas D. P. Cosford. Rapid Multistep Synthesis of 1,2,4-Oxadiazoles in a Single Continuous Microreactor Sequence. The Journal of Organic Chemistry 2008, 73 (18) , 7219-7223. https://doi.org/10.1021/jo801152c
16. Alexandre Gagnon, Martin Duplessis, Pamela Alsabeh and Francis Barabé. Palladium-Catalyzed Cross-Coupling Reaction of Tricyclopropylbismuth with Aryl Halides and Triflates. The Journal of Organic Chemistry 2008, 73 (9) , 3604-3607. https://doi.org/10.1021/jo702377h
17. Yuuki Koide,, Kazuhiro Uemoto,, Takeshi Hasegawa,, Tomoyuki Sada,, Akira Murakami,, Hiroshi Takasugi,, Atsuko Sakurai,, Naoki Mochizuki,, Atsuo Takahashi, and, Atsushi Nishida. Pharmacophore-Based Design of Sphingosine 1-phosphate-3 Receptor Antagonists That Include a 3,4-Dialkoxybenzophenone Scaffold. Journal of Medicinal Chemistry 2007, 50 (3) , 442-454. https://doi.org/10.1021/jm060834d
18. Congcong Yan, Min Zhang, Jiaxin Li, Jinli Zhang, Yangjie Wu. Thiol-promoted intermolecular cyclization to synthesize 1,2,4-oxadiazoles including tioxazafen under transition metal-free conditions. Organic & Biomolecular Chemistry 2023, 21 (27) , 5616-5621. https://doi.org/10.1039/D3OB00770G
19. Shweta Singh, Jeyakumar Kandasamy. Synthesis of Acyl Hydrazides from Carboxamides and Hydrazine Hydrate Under Metal‐Free Conditions at Room Temperature. Asian Journal of Organic Chemistry 2023, 12 (6) https://doi.org/10.1002/ajoc.202300115
20. Omid Jamshidi Kandjani, Shadi Yaqoubi, Samad Shams Vahdati, Behnam Borhannejad, Siavoush Dastmalchi, Ali Akbar Alizadeh. S1PR1 modulators in multiple sclerosis: Efficacy, safety, comparison, and chemical structure insights. European Journal of Medicinal Chemistry 2023, 250 , 115182. https://doi.org/10.1016/j.ejmech.2023.115182
21. Oleksandr O. Grygorenko, Kostiantyn P. Melnykov, Serhii Holovach, Oleksandr Demchuk. Fluorinated Cycloalkyl Building Blocks for Drug Discovery. ChemMedChem 2022, 17 (21) https://doi.org/10.1002/cmdc.202200365
22. Janine Cossy, Peter Polàk, Paul C. Ruer. Incorporation of a cyclobutyl substituent in molecules by transition metal-catalyzed cross-coupling reactions. Organic & Biomolecular Chemistry 2022, 20 (38) , 7529-7553. https://doi.org/10.1039/D2OB01045C
23. Oleksandr O. Grygorenko, Dmitriy M. Volochnyuk, Bohdan V. Vashchenko. Emerging Building Blocks for Medicinal Chemistry: Recent Synthetic Advances. European Journal of Organic Chemistry 2021, 2021 (47) , 6478-6510. https://doi.org/10.1002/ejoc.202100857
24. Yue Zhang, Chengjun Wu, Xinyi Wan, Cunde Wang. Direct synthesis of 3,5‐diaryl‐1,2, 4‐oxadiazoles using 1‐(2‐oxo‐2‐arylethyl)pyridin‐1‐iums with benzamidines. Journal of Heterocyclic Chemistry 2021, 58 (12) , 2287-2297. https://doi.org/10.1002/jhet.4354
25. Gullapalli. B. Dharma Rao, Bendi Anjaneyulu, Mahabir. P. Kaushik, Mailavaram. R. Prasad. β‐Ketoesters: An Overview and It's Applications via Transesterification. ChemistrySelect 2021, 6 (40) , 11060-11075. https://doi.org/10.1002/slct.202102949
26. Cristián M. Camacho, Marianela G. Pizzio, David L. Roces, Dora B. Boggián, Ernesto G. Mata, Yanina Bellizzi, Elizabeth Barrionuevo, Viviana C. Blank, Leonor P. Roguin. Design, synthesis and cytotoxic evaluation of a library of oxadiazole-containing hybrids. RSC Advances 2021, 11 (47) , 29741-29751. https://doi.org/10.1039/D1RA05602F
27. William J. Pitts, Alaric J. Dyckman. Multiple Sclerosis. 2021, 1-43. https://doi.org/10.1002/0471266949.bmc203.pub2
28. 祥东 孟. Research Progress of 3,5-Substituted-1,2,4-Oxadiazole Compounds. Hans Journal of Medicinal Chemistry 2021, 09 (02) , 67-77. https://doi.org/10.12677/HJMCe.2021.92009
29. Michiel Langeslag, Michaela Kress. The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain. Expert Opinion on Therapeutic Targets 2020, 24 (9) , 869-884. https://doi.org/10.1080/14728222.2020.1787989
30. Ran Li, Yu-Cheng Gu, Wen Zhang. Emerging Marine Immunomodulatory Small-molecules (2010- Present). Current Chemical Biology 2019, 13 (3) , 187-196. https://doi.org/10.2174/2212796813666190716102614
31. Kambappa Vinaya, Ganganahalli K. Chandrashekara, Prasanna D. Shivaramu. One-pot synthesis of 3,5-diaryl substituted-1,2,4-oxadiazoles using gem -dibromomethylarenes. Canadian Journal of Chemistry 2019, 97 (9) , 690-696. https://doi.org/10.1139/cjc-2018-0333
32. Tianqi Liu, Jing Jin, Yonghui Chen, Qiumu Xi, Jinping Hu, Wenqiang Jia, Xiaoguang Chen, Yan Li, Xiaojian Wang, Dali Yin. Identification and Structure–Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P1). Bioorganic Chemistry 2019, 82 , 41-57. https://doi.org/10.1016/j.bioorg.2018.09.008
33. Hassan A. Swarup, Nagaraju Chaithra, Kempegowda Mantelingu, Kanchugarkoppal S. Rangappa. Green Synthetic Approach for the Construction of 3,5‐Disubstituted 1,2,4‐Oxadiazoles and Ataluren Analogues from Dithioesters Using Water. ChemistrySelect 2018, 3 (19) , 5390-5394. https://doi.org/10.1002/slct.201800886
34. Christopher M. Tonge, Ethan R. Sauvé, Nathan R. Paisley, Jordan E. Heyes, Zachary M. Hudson. Polymerization of acrylates based on n-type organic semiconductors using Cu(0)-RDRP. Polymer Chemistry 2018, 9 (24) , 3359-3367. https://doi.org/10.1039/C8PY00670A
35. Luca Piali, Magdalena Birker‐Robaczewska, Cyrille Lescop, Sylvie Froidevaux, Nicole Schmitz, Keith Morrison, Christopher Kohl, Markus Rey, Rolf Studer, Enrico Vezzali, Patrick Hess, Martine Clozel, Beat Steiner, Martin H. Bolli, Oliver Nayler. Cenerimod, a novel selective S1P 1 receptor modulator with unique signaling properties. Pharmacology Research & Perspectives 2017, 5 (6) https://doi.org/10.1002/prp2.370
36. Kostiantyn P. Melnykov, Pavel S. Nosik, Bohdan B. Kurpil, Dmitriy A. Sibgatulin, Dmitriy M. Volochnyuk, Sergey V. Ryabukhin, Oleksandr O. Grygorenko. Synthesis of gem -difluorocyclopentane/hexane building blocks. Journal of Fluorine Chemistry 2017, 199 , 60-66. https://doi.org/10.1016/j.jfluchem.2017.04.012
37. Jatin J. Lade, Bhausaheb N. Patil, Kamlesh S. Vadagaonkar, Atul C. Chaskar. Oxidative cyclization of amidoximes and thiohydroximic acids: A facile and efficient strategy for accessing 3,5-disubstituted 1,2,4-oxadiazoles and 1,4,2-oxathiazoles. Tetrahedron Letters 2017, 58 (22) , 2103-2108. https://doi.org/10.1016/j.tetlet.2017.04.045
38. David Marcoux, Hai-Yun Xiao, T. G. Murali Dhar, Jenny Xie, Lois D. Lehman-McKeeman, Dauh-Rurng Wu, Marta Dabros, Xiaoxia Yang, Tracy L. Taylor, Xia D. Zhou, Elizabeth M. Heimrich, Rochelle Thomas, Kim W. McIntyre, Hong Shi, Paul C. Levesque, Huadong Sun, Zheng Yang, Anthony M. Marino, Georgia Cornelius, Celia J. D'Arienzo, Anuradha Gupta, Bala Pragalathan, Richard Rampulla, Arvind Mathur, Ding Ren Shen, Mary Ellen Cvijic, Luisa Salter-Cid, Louis J. Lombardo, Percy H. Carter, Alaric J. Dyckman. Identification of potent tricyclic prodrug S1P 1 receptor modulators. MedChemComm 2017, 8 (4) , 725-729. https://doi.org/10.1039/C6MD00539J
39. Ananda Herath, Nicholas D P Cosford. Continuous-flow synthesis of highly functionalized imidazo-oxadiazoles facilitated by microfluidic extraction. Beilstein Journal of Organic Chemistry 2017, 13 , 239-246. https://doi.org/10.3762/bjoc.13.26
40. Junqing Guo, Scott H. Watterson, Steven H. Spergel, James Kempson, Charles M. Langevine, Ding Ren Shen, Melissa Yarde, Mary Ellen Cvijic, Dana Banas, Richard Liu, Suzanne J. Suchard, Kathleen Gillooly, Tracy Taylor, Sandra Rex-Rabe, David J. Shuster, Kim W. McIntyre, Georgia Cornelius, Celia D’Arienzo, Anthony Marino, Praveen Balimane, Luisa Salter-Cid, Murray McKinnon, Joel C. Barrish, Percy H. Carter, William J. Pitts, Jenny Xie, Alaric J. Dyckman. Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1). Bioorganic & Medicinal Chemistry Letters 2016, 26 (10) , 2470-2474. https://doi.org/10.1016/j.bmcl.2016.03.105
41. Malleswara Rao Kuram, Woo Gyum Kim, Kyungjae Myung, Sung You Hong. Copper‐Catalyzed Direct Synthesis of 1,2,4‐Oxadiazoles from Amides and Organic Nitriles by Oxidative N–O Bond Formation. European Journal of Organic Chemistry 2016, 2016 (3) , 438-442. https://doi.org/10.1002/ejoc.201501502
42. Martin Braddock. Methods for Testing Immunological Factors. 2016, 2091-2203. https://doi.org/10.1007/978-3-319-05392-9_45
43. Rahim Hosseinzadeh-Khanmiri, Abolghasem Moghimi, Ahmad Shaabani, Hassan Valizadeh, Seik Weng Ng. Synthesis of 2-(1,2,4-oxadiazol-3-yl)quinazolin-4(3H)-ones from diaminoglyoxime-based nitrones. Molecular Diversity 2015, 19 (3) , 501-510. https://doi.org/10.1007/s11030-015-9588-0
44. Anna Quattropani, Wolfgang H. B. Sauer, Stefano Crosignani, Jerome Dorbais, Patrick Gerber, Jerome Gonzalez, Delphine Marin, Mathilde Muzerelle, Fanny Beltran, Anthony Nichols, Katrin Georgi, Manfred Schneider, Pierre‐Alain Vitte, Valerie Eligert, Laurence Novo‐Perez, Jennifer Hantson, Sebastien Nock, Susanna Carboni, Adriano Luis Soares de Souza, Jean‐François Arrighi, Ursula Boschert, Agnes Bombrun. Pharmacophore‐Based Design of Novel Oxadiazoles as Selective Sphingosine‐1‐phosphate (S1P) Receptor Agonists with in vivo Efficacy. ChemMedChem 2015, 10 (4) , 688-714. https://doi.org/10.1002/cmdc.201402557
45. Martin Braddock. Methods for Testing Immunological Factors. 2015, 1-131. https://doi.org/10.1007/978-3-642-27728-3_45-1
46. Yingjie Zhu, John Watson, Mengjie Chen, Ding Ren Shen, Melissa Yarde, Michele Agler, Neil Burford, Andrew Alt, Sukhanya Jayachandra, Mary Ellen Cvijic, Litao Zhang, Alaric Dyckman, Jenny Xie, Jonathan O’Connell, Martyn Banks, Andrea Weston. Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists. SLAS Discovery 2014, 19 (7) , 1079-1089. https://doi.org/10.1177/1087057114533146
47. Ramu Tadikonda, Mangarao Nakka, Mahaboob Basha Gajula, Srinuvasarao Rayavarapu, Padma Rao Gollamudi, Siddaiah Vidavalur. Efficient and Convenient Protocol for the Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazoles Using HClO 4 -SiO 2 as a Heterogeneous Recyclable Catalyst. Synthetic Communications 2014, 44 (13) , 1978-1986. https://doi.org/10.1080/00397911.2014.883633
48. Kaitlin J. Basham, Vasudev R. Bhonde, Collin Kieffer, James B.C. Mack, Matthew Hess, Bryan E. Welm, Ryan E. Looper. Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor. Bioorganic & Medicinal Chemistry Letters 2014, 24 (11) , 2473-2476. https://doi.org/10.1016/j.bmcl.2014.04.013
49. Barahman Movassagh, Farzaneh Talebsereshki. Mild and Efficient One-Pot Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazoles from Nitriles Mediated by K 3 PO 4. Synthetic Communications 2014, 44 (2) , 188-194. https://doi.org/10.1080/00397911.2013.797997
50. Michael A. Hanson, Robert Peach. Structural Biology of the S1P1 Receptor. 2014, 23-53. https://doi.org/10.1007/978-3-319-05879-5_2
51. Puneet K. Gupta, Mohd. Kamil Hussain, Mohd. Asad, Ruchir Kant, Rohit Mahar, Sanjeev K. Shukla, Kanchan Hajela. A metal-free tandem approach to prepare structurally diverse N-heterocycles: synthesis of 1,2,4-oxadiazoles and pyrimidinones. New J. Chem. 2014, 38 (7) , 3062-3070. https://doi.org/10.1039/C4NJ00361F
52. Tadikonda Ramu, Sarakula Prasanthi, Nakka Mangarao, Gajula Mahaboob Basha, Rayavarapu Srinuvasarao, Vidavalur Siddaiah. A Simple and Straightforward Protocol to 3,5-Disubstituted 1,2,4-Oxadiazoles from Carboxylic Acids. Chemistry Letters 2013, 42 (7) , 722-724. https://doi.org/10.1246/cl.130187
53. Abby L. Parrill, Gabor Tigyi. Integrating the puzzle pieces: The current atomistic picture of phospholipid–G protein coupled receptor interactions. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013, 1831 (1) , 2-12. https://doi.org/10.1016/j.bbalip.2012.09.002
54. Nuria Aguilar, Marta Mir, Pedro M. Grima, Manel López, Victor Segarra, Laia Esteban, Imma Moreno, Nuria Godessart, Gema Tarrasón, Teresa Domenech, Dolors Vilella, Clara Armengol, Mònica Córdoba, Mar Sabaté, Daniel Casals, Maria Domínguez. Discovery of a novel class of zwitterionic, potent, selective and orally active S1P1 direct agonists. Bioorganic & Medicinal Chemistry Letters 2012, 22 (24) , 7672-7676. https://doi.org/10.1016/j.bmcl.2012.09.110
55. CRAIG A. MILLER. S1P Receptor Agonists. 2012, 417-443. https://doi.org/10.1039/9781849735346-00417
56. Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, Yumiko Mizuno, Kazuhiko Tamaki, Futoshi Nara, Yumi Kawase, Yoshiyuki Yabe, Daisuke Nakai, Emi Kamiyama, Yoko Urasaki-Kaneno, Takaichi Shimozato, Hiromi Doi-Komuro, Takashi Kagari, Wataru Tomisato, Ryotaku Inoue, Miyuki Nagasaki, Hiroshi Yuita, Keiko Oguchi-Oshima, Reina Kaneko, Takahide Nishi. Synthesis and evaluation of CS-2100, a potent, orally active and S1P3- sparing S1P1 agonist. European Journal of Medicinal Chemistry 2012, 51 , 92-98. https://doi.org/10.1016/j.ejmech.2012.02.022
57. Heng Xu, Haibo Zhang, Linbo Luan, Yan Xu, Chengyong Li, Yonghui Wang, Fangbin Han, Ting Yang, Feng Ren, Jia-Ning Xiang, John D. Elliott, Yonggang Zhao, Taylor B. Guo, Hongtao Lu, Wei Zhang, David Hirst, Matthew Lindon, Xichen Lin. Discovery of thiadiazole amides as potent, S1P3-sparing agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorganic & Medicinal Chemistry Letters 2012, 22 (7) , 2456-2459. https://doi.org/10.1016/j.bmcl.2012.02.016
58. Alaric J. Dyckman. Recent Advances in the Discovery and Development of Sphingosine-1-Phosphate-1 Receptor Agonists. 2012, 195-207. https://doi.org/10.1016/B978-0-12-396492-2.00013-8
59. Gema Tarrasón, Mariona Aulí, Sanam Mustafa, Vladislav Dolgachev, Maria Teresa Domènech, Neus Prats, María Domínguez, Rosa López, Nuria Aguilar, Marta Calbet, Mercè Pont, Graeme Milligan, Steven L. Kunkel, Nuria Godessart. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice. International Immunopharmacology 2011, 11 (11) , 1773-1779. https://doi.org/10.1016/j.intimp.2011.07.004
60. Babak Kaboudin, Leila Malekzadeh. Organic reactions in water: an efficient method for the synthesis of 1,2,4-oxadiazoles in water. Tetrahedron Letters 2011, 52 (48) , 6424-6426. https://doi.org/10.1016/j.tetlet.2011.09.081
61. J.J. Aarthi, M.A. Darendeliler, P.N. Pushparaj. Dissecting the Role of the S1P/S1PR Axis in Health and Disease. Journal of Dental Research 2011, 90 (7) , 841-854. https://doi.org/10.1177/0022034510389178
62. Andrea Porcheddu, Roberta Cadoni, Lidia De Luca. A fast and efficient one-pot microwave assisted synthesis of variously di-substituted 1,2,4-oxadiazoles. Organic & Biomolecular Chemistry 2011, 9 (21) , 7539. https://doi.org/10.1039/c1ob06055d
63. Jerold Chun, Timothy Hla, Kevin R. Lynch, Sarah Spiegel, Wouter H. Moolenaar. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature: TABLE 1. Pharmacological Reviews 2010, 62 (4) , 579-587. https://doi.org/10.1124/pr.110.003111
64. Donna M. Huryn. Multiple Sclerosis. 2010, 547-568. https://doi.org/10.1002/0471266949.bmc203
65. Dong-Soon Im. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. Acta Pharmacologica Sinica 2010, 31 (9) , 1213-1222. https://doi.org/10.1038/aps.2010.135
66. Yibin Xiang, Bradford Hirth, John L. Kane, Junkai Liao, Kevin D. Noson, Christopher Yee, Gary Asmussen, Maria Fitzgerald, Christine Klaus, Michael Booker. Discovery of novel sphingosine kinase-1 inhibitors. Part 2. Bioorganic & Medicinal Chemistry Letters 2010, 20 (15) , 4550-4554. https://doi.org/10.1016/j.bmcl.2010.06.019
67. Frédéric J. Zécri, Rainer Albert, Gregory Landrum, Klaus Hinterding, Nigel G. Cooke, Danilo Guerini, Markus Streiff, Christian Bruns, Barbara Nuesslein-Hildesheim. Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P1) receptor agonists. Bioorganic & Medicinal Chemistry Letters 2010, 20 (1) , 35-37. https://doi.org/10.1016/j.bmcl.2009.11.045
68. Laetitia Duchet, Jean Christophe Legeay, Daniel Carrié, Ludovic Paquin, Jean Jacques Vanden Eynde, Jean Pierre Bazureau. Synthesis of 3,5-disubstituted 1,2,4-oxadiazoles using ionic liquid-phase organic synthesis (IoLiPOS) methodology. Tetrahedron 2010, 66 (4) , 986-994. https://doi.org/10.1016/j.tet.2009.11.079
69. Alessio Terenzi, Giampaolo Barone, Antonio Palumbo Piccionello, Gianluca Giorgi, Annalisa Guarcello, Patrizia Portanova, Giuseppe Calvaruso, Silvestre Buscemi, Nicolò Vivona, Andrea Pace. Synthesis, characterization, cellular uptake and interaction with native DNA of a bis(pyridyl)-1,2,4-oxadiazole copper(ii) complex. Dalton Transactions 2010, 39 (38) , 9140. https://doi.org/10.1039/c0dt00266f
70. Kensuke Okuda, Ying-Xue Zhang, Hiromi Ohtomo, Takashi Hirota, Kenji Sasaki. Polycyclic N-Heterocyclic Compounds. Part 62: Reaction of N-(Quinazolin-4-yl)amidine Derivatives with Hydroxylamine Hydrochloride and Anti-platelet Aggregation Activity of the Products. Chemical and Pharmaceutical Bulletin 2010, 58 (3) , 369-374. https://doi.org/10.1248/cpb.58.369
71. V. I. Potkin, S. K. Petkevich, P. V. Kurman. Synthesis of 5-substituted 3-[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]-1,2,4-oxadiazoles. Russian Journal of Organic Chemistry 2009, 45 (4) , 551-554. https://doi.org/10.1134/S1070428009040137
72. S.-K. Jo, A. Bajwa, A.S. Awad, K.R. Lynch, M.D. Okusa. Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease. Kidney International 2008, 73 (11) , 1220-1230. https://doi.org/10.1038/ki.2008.34
73. Hugh Rosen, Pedro Gonzalez‐Cabrera, David Marsolais, Stuart Cahalan, Anthony S. Don, M. Germana Sanna. Modulating tone: the overture of S1P receptor immunotherapeutics. Immunological Reviews 2008, 223 (1) , 221-235. https://doi.org/10.1111/j.1600-065X.2008.00645.x
74. Janaína V. dos Anjos, Denis Sinou, Sebastiao J. de Melo, Rajendra M. Srivastava. Synthesis of glycosyl-triazole linked 1,2,4-oxadiazoles. Carbohydrate Research 2007, 342 (16) , 2440-2449. https://doi.org/10.1016/j.carres.2007.07.011
75. Mor M. Naor, Michelle D. Walker, James R. Van Brocklyn, Gabor Tigyi, Abby L. Parrill. Sphingosine 1-phosphate pKa and binding constants: Intramolecular and intermolecular influences. Journal of Molecular Graphics and Modelling 2007, 26 (2) , 519-528. https://doi.org/10.1016/j.jmgm.2007.03.004
76. Tsuyoshi Nakamura, Kiyoaki Yonesu, Yumiko Mizuno, Chie Suzuki, Yuki Sakata, Yoh Takuwa, Futoshi Nara, Susumu Satoh. Synthesis and SAR studies of a novel class of S1P1 receptor antagonists. Bioorganic & Medicinal Chemistry 2007, 15 (10) , 3548-3564. https://doi.org/10.1016/j.bmc.2007.02.048
77. Wu Du, Quang Truong, Hongbo Qi, Yan Guo, Harry R. Chobanian, William K. Hagmann, Jeffrey J. Hale. A one-pot synthesis of 3-substituted-5-carbonylmethyl-1,2,4-oxadiazoles from β-keto esters and amidoximes under solvent-free conditions. Tetrahedron Letters 2007, 48 (13) , 2231-2235. https://doi.org/10.1016/j.tetlet.2007.02.005
78. Qiaolin Deng, Joseph A. Clemas, Gary Chrebet, Paul Fischer, Jeffrey J. Hale, Zhen Li, Sander G. Mills, James Bergstrom, Suzanne Mandala, Ralph Mosley, Stephen A. Parent. Identification of Leu276 of the S1P 1 Receptor and Phe263 of the S1P 3 Receptor in Interaction with Receptor Specific Agonists by Molecular Modeling, Site-Directed Mutagenesis, and Affinity Studies. Molecular Pharmacology 2007, 71 (3) , 724-735. https://doi.org/10.1124/mol.106.029223
79. Hans Gerhard Vogel. Antiarthrotic and Immunomodulatory Activity. 2007, 1117-1190. https://doi.org/10.1007/978-3-540-70995-4_10
80. J.S. Skotnicki, D.M. Huryn. Treatment of Transplantation Rejection and Multiple Sclerosis. 2007, 917-934. https://doi.org/10.1016/B0-08-045044-X/00233-9
81. Nigel Cooke, Frédéric Zécri. Chapter 16 Sphingosine 1-Phosphate Type 1 Receptor Modulators: Recent Advances and Therapeutic Potential. 2007, 245-263. https://doi.org/10.1016/S0065-7743(07)42016-4
82. Benito Alcaide, Pedro Almendros. Four-membered ring systems. 2007, 106-125. https://doi.org/10.1016/S0959-6380(07)80008-0
83. Kunitomo Adachi, Kenji Chiba. FTY720 Story. Its Discovery and the following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology. Perspectives in Medicinal Chemistry 2007, 1 , 1177391X0700100. https://doi.org/10.1177/1177391X0700100002
84. Thomas Herzinger, Burkhard Kleuser, Monika Schäfer-Korting, Hans Christian Korting. Sphingosine-1-Phosphate Signaling and the Skin. American Journal of Clinical Dermatology 2007, 8 (6) , 329-336. https://doi.org/10.2165/00128071-200708060-00002
85. Shifeng Pan, Yuan Mi, Charles Pally, Christian Beerli, Alice Chen, Danilo Guerini, Klaus Hinterding, Barbara Nuesslein-Hildesheim, Tove Tuntland, Sophie Lefebvre, Yi Liu, Wenqi Gao, Alan Chu, Volker Brinkmann, Christian Bruns, Markus Streiff, Catherine Cannet, Nigel Cooke, Nathanael Gray. A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model. Chemistry & Biology 2006, 13 (11) , 1227-1234. https://doi.org/10.1016/j.chembiol.2006.09.017
86. Lin Yan, Richard Budhu, Pei Huo, Christopher L. Lynch, Jeffrey J. Hale, Sander G. Mills, Richard Hajdu, Carol A. Keohane, Mark J. Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James Bergstrom, Deborah Card, Suzanne M. Mandala. 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters 2006, 16 (13) , 3564-3568. https://doi.org/10.1016/j.bmcl.2006.03.090
87. Petr Vachal, Leslie M. Toth, Jeffrey J. Hale, Lin Yan, Sander G. Mills, Gary L. Chrebet, Carol A. Koehane, Richard Hajdu, James A. Milligan, Mark J. Rosenbach, Suzanne Mandala. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorganic & Medicinal Chemistry Letters 2006, 16 (14) , 3684-3687. https://doi.org/10.1016/j.bmcl.2006.04.064
88. Lin Yan, Pei Huo, George Doherty, Lesile Toth, Jeffrey J. Hale, Sander G. Mills, Richard Hajdu, Carol A. Keohane, Mark J. Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James Bergstrom, Deborah Card, Elizabeth Quackenbush, Alexandra Wickham, Suzanne M. Mandala. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Bioorganic & Medicinal Chemistry Letters 2006, 16 (14) , 3679-3683. https://doi.org/10.1016/j.bmcl.2006.04.084
89. Vincent J. Colandrea, Irene E. Legiec, Pei Huo, Lin Yan, Jeffrey J. Hale, Sander G. Mills, James Bergstrom, Deborah Card, Gary Chebret, Richard Hajdu, Carol Ann Keohane, James A. Milligan, Mark J. Rosenbach, Gan-Ju Shei, Suzanne M. Mandala. 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Bioorganic & Medicinal Chemistry Letters 2006, 16 (11) , 2905-2908. https://doi.org/10.1016/j.bmcl.2006.03.038